StonvexLoading…
StonvexStonvexStonvexCore line items from MPX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $66.53M | $244.42M | $179.85M | $126.70M |
Operating Income | $-2.72M | $14.03M | $10.29M | $7.42M |
Net Income | $-2.06M | $11.38M | $9.02M | $4.16M |
EPS (Diluted) | $-0.06 | $0.32 | $0.25 | $0.18 |
Total Assets | $149.20M | $147.23M | $179.45M | $173.25M |
Total Liabilities | $31.14M | $22.27M | $53.20M | $46.01M |
Cash & Equivalents | $45.80M | $43.51M | $47.40M | $50.17M |
Free Cash Flow OCF − CapEx | $8.55M | $14.92M | $10.77M | $8.64M |
Shares Outstanding | 35.23M | 35.00M | 35.00M | 35.00M |